QT Prolongation Draft Guidance Urges Single Clinical Trial For Evaluation
This article was originally published in The Pink Sheet Daily
Executive Summary
The ECG trial should be early in clinical development (but not the first study) should be carried out in healthy volunteers and include a positive control group, FDA’s draft guidance says.